Medscape InDiscussion: Mantle Cell Lymphoma
Activity Overview
Episode publication activity over the past year
Episodes
Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: Mutations and Mechanisms of Resistance
31 May 2023
Contributed by Lukas
Drs Peter Martin and Anita Kumar discuss covalent and noncovalent Bruton tyrosine kinase (BTK) inhibitors in the frontline setting, BTK mutations, and...
Pathology of Mantle Cell Lymphoma: Biopsies, Diagnostic Markers, and Options for Clinicians Treating This Disease
27 Apr 2023
Contributed by Lukas
Drs Peter Martin and Eric Hsi have a thought-provoking discussion on key topics in the pathology of mantle cell lymphoma, including biopsies, diagnost...
CAR T Cells and Immunotherapy in Mantle Cell Lymphoma: Bridging Therapy, Toxicities, and Bispecific Antibodies
30 Mar 2023
Contributed by Lukas
Drs Peter Martin and Michael Wang discuss the role of CAR T cells in mantle cell lymphoma, how they are used with respect to bridging therapy, and the...
The Past, Present, and Future of Bendamustine in Mantle Cell Lymphoma
28 Feb 2023
Contributed by Lukas
Drs Peter Martin and Kami Maddocks discuss bendamustine, its effectiveness in older patients, and the challenge of combining treatments or other medic...
Unpacking the Addition of New Variables to the Mantle Cell Lymphoma International Prognostic Index and MRD
31 Jan 2023
Contributed by Lukas
Drs Peter Martin and Eva Hoster discuss minimal residual disease, the Mantle Cell Lymphoma International Prognostic Index, and newer variable addition...
Autologous Stem Cell Transplant for Mantle Cell Lymphoma and the Transition Toward the Use of BTK Inhibitors
31 Jan 2023
Contributed by Lukas
Drs Peter Martin and Brad Kahl discuss autologous stem cell transplantation for mantle cell lymphoma, the TRIANGLE trial results, and the transition t...